Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download the PDF here. This post appeared first on investingnews.com 0 Related Posts LAURION Strengthens its Technical Leadership at Ishkoday with Appointment of Pierre-Jean Lafleur, P.Eng., as Qualified Person January 21, 2026 Walker Lane Resources Ltd. Completes an Updated Mineral Resource and Plans in 2026 to Advance Exploration Efforts and a Preliminary Economic Assessment in its Silver Hart Project, Yukon, Canada January 21, 2026 Excellent Results from 2025 Core Drilling Program at McDermitt January 21, 2026
LAURION Strengthens its Technical Leadership at Ishkoday with Appointment of Pierre-Jean Lafleur, P.Eng., as Qualified Person January 21, 2026
Walker Lane Resources Ltd. Completes an Updated Mineral Resource and Plans in 2026 to Advance Exploration Efforts and a Preliminary Economic Assessment in its Silver Hart Project, Yukon, Canada January 21, 2026